4//SEC Filing
SIGA TECHNOLOGIES INC 4
Accession 0001179022-09-000100
$SIGACIK 0001010086operating
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:30 PM ET
Size
10.9 KB
Accession
0001179022-09-000100
Insider Transaction Report
Form 4
MJALLI ADNAN M M
Director
Transactions
- Tax Payment
Common Stock
2009-09-30$7.80/sh−444,665$3,468,387→ 3,851,969 total(indirect: by TransTech Pharma, Inc.) - Sale
Common Stock
2009-09-30$6.24/sh−3,851,969$24,036,287→ 0 total(indirect: by TransTech Pharma, Inc.) - Exercise of In-Money
Warrant (right to buy)
2009-09-30−1,824,412→ 0 total(indirect: By TransTech Pharma, Inc.)Exercise: $1.90From: 2004-01-08Exp: 2011-01-08→ Common Stock (1,824,412 underlying) - Exercise of In-Money
Common Stock, par value $0.0001 per share ("Common Stock")
2009-09-30$1.90/sh+1,824,412$3,466,383→ 4,296,634 total(indirect: by TransTech Pharma, Inc.)
Footnotes (2)
- [F1]On September 30, 2009, TransTech Pharma, Inc. sold 3,851,969 shares of Common Stock in a privately negotiated transaction to STH Partners, L.P.
- [F2]The shares of Common Stock and the warrants were beneficially owned by TransTech Pharma, Inc. The reporting person is the President, Chief Executive Officer and a director of TransTech Pharma, Inc. The reporting person disclaims beneficial ownership of the securities beneficially owned by TransTech Pharma, Inc. except to the extent of his pecuniary interest therein.
Documents
Issuer
SIGA TECHNOLOGIES INC
CIK 0001010086
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001010086
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:30 PM ET
- Size
- 10.9 KB